Boehringer Ingelheim enriches drug pipeline
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of ...Read more
China will overtake Japan in R&D spending: Report
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2013
Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, inve...Read more
Astellas gets FDA nod for kidney transplant drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...Read more
Global collaborations is the way forward for drug discovery
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 19 Dec, 2012
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...Read more
NIH gives $2.2 mn to VaxInnate for dengue vaccine
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2013
Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provi...Read more
Janssen to develop therapy for immunological diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and c...Read more
European Commission nod for Novartis' Exjade
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 26 Dec, 2012
Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring ch...Read more
CSL hemophilia therapy gets orphan drug status
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 11 Jun, 2012
Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP...Read more
John Vernachio is Arthritis Foundation research VP
Drug Discovery | Influencers | By BioSpectrum Bureau | 3 Comment | 16 Apr, 2013
Singapore: Arthritis Foundation appointed Dr John Vernachio as vice president of research, effective April 15. In his ne...Read more
FDA gets biomarker database license from GVK Bio
Drug Discovery | Regulatory | By BioSpectrum Bureau | 2 Comment | 05 Feb, 2013
Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification ...Read more
Otsuka, Lundbeck files NDA for schizophrenia drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...Read more
NIH study: Diabetes drug Metformin extends life
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when s...Read more
Accelerating drug discovery process
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2012
In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platform...Read more
Boehringer to open $46 mn biologics plant in Shanghai
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2013
Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer co...Read more
Recycled plastic can kill drug-resistant fungi
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2013
Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research...Read more
Novartis liver cancer trial with Afinitor flops
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2013
Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not e...Read more
Oramed submits pre-IND for exenatide to FDA
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 02 Aug, 2013
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (...Read more
Aussie drug delivery firm raises $19.3 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to...Read more